Bml Capital Management, LLC / ORMP
Bml Capital Management, LLC’s Oramed Pharmaceuticals Inc Position
Does Bml Capital Management, LLC own Oramed Pharmaceuticals Inc (ORMP)? Yes — 3.17M shares worth $11M (+6.91% of its 13F portfolio) as of Q1 2026.
Position Value
$11M
Q1 2026
Shares
3.17M
% of Portfolio
+6.91%
Quarters Held
13
currently held
Position History ORMP
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 3.17M | $11M | +6.91% |
| Q4 2025 | 3.17M | $9M | +7.80% |
| Q3 2025 | 3.17M | $8M | +7.66% |
| Q2 2025 | 3.08M | $7M | +5.25% |
| Q1 2025 | 3.02M | $6M | +5.23% |
| Q4 2024 | 2.64M | $6M | +3.97% |
| Q3 2024 | 2.19M | $5M | +3.14% |
| Q2 2024 | 1.35M | $3M | +2.47% |
| Q1 2024 | 844.5K | $2M | +1.63% |
| Q4 2023 | 1.26M | $3M | +2.21% |
| Q3 2023 | 781.3K | $2M | +1.87% |
| Q2 2023 | 850.0K | $3M | +2.74% |
| Q1 2023 | 1.36M | $3M | +2.56% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bml Capital Management, LLC’s full portfolio or all institutional holders of ORMP.